Chemical Structure and Classification
Chemically, naphazoline (Naphtysinum) belongs to the imidazoline derivatives. This structural group also includes oxymetazoline, xylometazoline, and tetryzoline.
Pharmacologically, the drug is classified among agents that regulate the peripheral nervous system. By mechanism of action, it is a predominantly locally acting $\alpha_2$-adrenergic agonist.
Pharmacodynamics and Mechanism of Action
The primary target of the drug is peripheral $\alpha_2$-adrenergic receptors.
Upon stimulation of these receptors, naphazoline produces a pronounced vasoconstrictive effect (vasoconstriction).
Pharmacological comparison: It is important to note that the vasoconstrictive effect of imidazoline derivatives (including naphazoline) is longer-lasting than that of classic $\alpha_1$-adrenergic agonists such as phenylephrine.
Clinical Application in ENT Practice
The drug is available in various topical formulations: drops, sprays, and emulsions. Its main clinical indication is intranasal administration for rhinitis.
The mechanism of the therapeutic effect follows a sequential cascade:
- Local vasoconstriction of the nasal mucosa blood vessels.
- Reduction of local tissue edema.
- Improvement of mucus drainage from the paranasal sinuses.
- Decreased blood flow to venous sinusoids.
Clinical result: Rapid and effective relief of nasal congestion and restored breathing.
Systemic (Central) Effects of Alpha-2 Adrenergic Agonists
Although naphazoline is used as a topical agent, students must understand the systemic effects of the entire $\alpha_2$-adrenergic agonist class. Centrally acting agents in this group include clonidine, guanfacine, methyldopa, and tizanidine.
Upon systemic absorption (entering the systemic circulation) and stimulation of $\alpha_2$-adrenergic receptors in the CNS, the following effects develop:
- Hypotensive — clinically significant reduction in blood pressure.
- Sedative — pronounced calming effect on the nervous system.
- Analgesic — systemic pain relief.
- Hypothermic — lowering of body temperature.
Formulations and Prescription Guidelines
The medication is prescribed as solutions of varying concentrations.
- Formulation: Solution in 0.05% and 0.1% concentrations in 10 mL vials.
- Administration: 2–3 drops into each nasal passage 3–4 times daily.
Prescription example:
`Rp.: Sol. Naphtysini 0.1% - 10 ml` `D.S. Instill 2-3 drops into each nasal passage 3-4 times a day.`